Kodiak Sciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KOD and other ETFs, options, and stocks.About KOD
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD.
KOD Key Statistics
Stock Snapshot
With a market cap of 1.03B, Kodiak Sciences(KOD) trades at $19.51. The stock has a price-to-earnings ratio of -4.74.
As of 2025-11-15, Kodiak Sciences(KOD) stock has fluctuated between $18.38 and $20.50. The current price stands at $19.51, placing the stock +6.1% above today's low and -4.8% off the high.
The Kodiak Sciences(KOD)'s current trading volume is 683.68K, compared to an average daily volume of 698.05K.
In the last year, Kodiak Sciences(KOD) shares hit a 52-week high of $21.17 and a 52-week low of $1.92.
In the last year, Kodiak Sciences(KOD) shares hit a 52-week high of $21.17 and a 52-week low of $1.92.
KOD News
Kodiak Sciences ( (KOD) ) has released its Q3 earnings. Here is a breakdown of the information Kodiak Sciences presented to its investors. Meet Your ETF AI Ana...
Kodiak Sciences announced new Phase 3 clinical trial data at the American Academy of Ophthalmology meetings showing that intraocular interleukin-6 inhibition wi...
